Vector-based SARS-CoV-2 vaccination is associated with improved T-cell responses in hematological neoplasia
Description
In order to elucidate mechanisms for SARS-CoV-2 vaccination success in hematological neoplasia, we herein provide a comprehensive characterization of the spike-specific T-cell and serological immunity induced in 130 patients in comparison to 91
